Merck settles suit over Vytorin trial; India fines ex-Ranbaxy director for insider trading;

@FiercePharma: Pennsylvania appeals court affirms $45M in Prempro damages; Pfizer says it'll go to state supreme court. Report | Follow @FiercePharma

> Merck ($MRK) agreed to pay $5 million in attorneys' fees and tweak its corporate governance rules to settle a shareholder suit over the delayed Enhance trial results. Story

> Indian regulators fined a former Ranbaxy Laboratories director and his wife for insider trading in Orchid Chemicals & Pharmaceuticals in 2008. Report

> U.K. regulators will review Shire's ADHD remedy Venvanse, sold as Vyvanse in the U.S., which would be the first amphetamine-based drug for the disorder in the EU if approved. Article

> Using certain seizure drugs in combination with HIV fighters can cause the antivirals to fail or reduce the effectiveness of the epilepsy meds, a new study finds. Release

> Eye drug maker Ista Pharmaceuticals says it's looking for higher sales and profits in 2012, with revenue expected to hit $180 million to $195 million. News

> Insys Therapeutics won FDA approval for its cancer pain drug Subsys, a sublingual fentanyl spray. Release

> Almost 33% of U.K. patients don't fill their prescriptions, saying they didn't have time or didn't want to pay for it. Story

> Rodman & Renshaw started covering Amylin ($AMLN) stock with an "underperform" rating and an $8 price target. Item

Biotech News

@FierceBiotech: Bleak forecast puts Lilly's R&D game plan to the test. Will this change Lechleiter's approach? Article | Follow @FierceBiotech

@JohnCFierce: Germany's Apogenix raises 7.5ME for glioblastoma drug work. Release | Follow @JohnCFierce

@RyanMFierce: Here's my own take on @Quintiles new digital patient unit, with insights from the group's chief: Story | Follow @RyanMFierce

@FierceMedDev: FDA Orders Safety Evaluation of Vaginal Mesh--Bloomberg. Article | Follow @FierceMedDev

> Fast-growing Forma grabs $815M cancer discovery deal with Boehringer. News

> Bleak forecast puts Eli Lilly's ambitious R&D game plan to the test. More

> Merck spinout nails promising study on hep C vaccine. Story

Manufacturing News

> Novartis adds OTC drug plant to GMP fix list. News

> AZ starts work on record-setting plant in China. Item

> Report: Big Pharma finds Indian collaborations costly. Story

> Pharma fires, pollution targeted in India. More

> Hospira enters angry-investor phase of remediation. Article

> Expired-drug take vs. toss debate gets new vetting. Story

Vaccine News

> Study: Most girls who get HPV vax say they see need to practice safe sex. Item

> FDA approves Pfizer's Prevnar 13 for adults over 50. Article

> Argentina fines GSK $93K for Synflorix vaccine trial in which 14 babies died. News

And Finally... Missed some FDA guidance last year? in-Pharma Technologist rounds up 2011's documents. Report

Suggested Articles

Besides paying $729 million to settle notorious kickback allegations, Novartis has promised to put strict restrictions on its future speaker programs.

Pharma companies including Pfizer and Novartis paused advertising on Facebook for July to protest hate and disinformation on the platform.

CureVac and Tesla are teaming up to produce the German vaccine maker's molecular RNA printers, Tesla CEO Elon Musk tweeted Thursday.